Evidence map›Paper›PMID 40062747›Full record

ArticleMicrobiology spectrum2025

Clinical presentation, treatment, and antimicrobial susceptibility of 155 sequential

Kurt D Palumbo, Natasia F Jacko, Michael Z David

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kurt D PalumboDivision of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0009-0007-7890-1537
Natasia F JackoDivision of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-8295-7951
Michael Z DavidDivision of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-1926-7800

Funding

Genomics of S. Aureus Colonization after Initial and Recurrent Skin Infections and the Impact of AntibioticsR01AI139188 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID, MICHAEL ZDENEK · 2018 to 2022
$3.8M
Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination)R01AI158452 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Michael Zdenek David · 2022 to 2026
$3.5M
NIAID NIH HHS R01 AI139188NIAID NIH HHS R01 AI158452
6 · The paper itself

Abstract

IMPORTANCE: In recent years,

Indexed as

Anti-Bacterial AgentsStaphylococcal InfectionsStaphylococcus lugdunensisAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedTertiary Care CentersUnited StatesAnti-Bacterial Agentsantimicrobial resistancebacteremiaepidemiologyskin and soft tissue infectionStaphylococcus lugdunensis

Identifiers

PMID40062747
PMCPMC11960052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.